Michelle Rheault, MD
@rheaultm.bsky.social
Ped nephrologist, #NephJC, MN girl, COI: several. Alis volat propriis. Breast cancer survivor, Pronounced “row”, (she/her). Bluesky is not a dating app.
As I told @monicatorrr.bsky.social of @huffpost.com, "As [women] grow older and more mature in their careers, they lose some of the fear of speaking their mind. And certain men don’t like that." www.huffpost.com/entry/age-di...
Data Reveals An Infuriating Reason Women Over 40 Are Held Back At Work
A recent study exposes how insidious age discrimination is — and it should make you mad.
huffpost.com
Your 50’s can seem like decade when you're supposed to have life figured out. But for many people, they're a time of change, uncertainty and growth…
MPR News@mprnews.org · 2w agoYour 30s can seem like decade when you're supposed to have life figured out. But for many people, they're a time of change, uncertainty and growth. Coming up at 9 a.m. on Thursday, guest host Kyra Miles talks about the myths, the realities and the opportunities that come with life in your 30s.
This is a superb educational episode Everything you wanted to know about C3G with Prof Carla Nester www.nephjc.com/freelyfilter... @freelyfiltered.bsky.social
FF94 C3 Glomerulopathy with Carla Nester — NephJC
The Valient Trial with Carla Nester
nephjc.com
Happy to share our 📜 "The Exam Room as Sanctuary - Caring for Undocumented Patients" Led by Dr. Miguel Linares at UCLA. www.nejm.org/doi/full/10....
A #NephJC short of the telitacicept trial from @nephromommy-akshu.bsky.social www.nephjc.com/news/2026/sh... IMO the exciting part of the early signal of GFR stabilization - if this is recapitulated with atacicept and sibeprelimab - then we can truly say IgAN remission is here and achievable
NephJC Short: When BAFF Meets APRIL: Telitacicept in IgA Nephropathy (TELIGAN trial) — NephJC
Does Dual BAFF/APRIL Blockade with Telitacicept Reduce Proteinuria in Persistent Proteinuric IgA Nephropathy?
nephjc.com
In neonates with anhydramnios due to #fetal #kidney failure, serial #amnioinfusions before 26 weeks improved early survival outcomes, but many survivors required ongoing dialysis or kidney transplant and experienced significant morbidity. ja.ma/4wjibTR
To every transgender Minnesotan: you belong here. This decision does not change MN's law or our commitment to protecting LGBTQ+ people. Today's rulings remind us that defending the rule of law also means defending the rights and dignity of every person. I'll never stop fighting to do both. 8/8
How do you sell Paella to Minnesotans? “The hotdish of Spain” 😂
It's time to start planning #NephMadness 2027! We would love your input as we start planning next year's tournament. Share your ideas: bit.ly/NM27Ideas @nephrosparks.bsky.social @annaburgner.bsky.social @kidneywars.bsky.social @catochita.bsky.social @ajkd.bsky.social
#NephMadness 2027: Call for Topic Suggestions
NephMadness 2026 is still fresh in our memories, but it’s already time to start thinking about NephMadness 2027! Which topics would you like to see in next year’s edition of the madness…
bit.ly
We need to make sure this editorial goes viral Misguided Brushes of a Pen Continue to Dismantle and Destroy Biomedical Research in the United States: We Can No Longer Afford Complacency and Fear. We Must All Act Now! diabetesjournals.org/care/article...
The CEO of the American Diabetes Association is Charles D. "Chuck" Henderson. The Chief Medical and Scientific Officer is Rita Rastogi Kalyani. They should be ashamed of themselves.
Jeremy Faust, MD@jeremyfaust.bsky.social · 2mo agoIncredibly disturbing story broken by @medpagetoday.com team. www.medpagetoday.com/special-repo...
We have multiple faculty positions open at UMN, one is research intensive, the other is primarily clinical. Feel free to reach out if interested or see the links below! umphysicians.wd1.myworkdayjobs.com/en-US/umpcar... umphysicians.wd1.myworkdayjobs.com/en-US/umpcar...
Infectious Diseases Physician - Assistant Professor
Program / Unit Description The Division of Infectious Diseases & International Medicine at the University of Minnesota is a globally recognized leader in clinical research and implementation scien...
umphysicians.wd1.myworkdayjobs.com
Crazy happenings at the #ADA26 Cops show up, snatch papers and shove scientists out www.medpagetoday.com/special-repo...
Video: Police Tussle With Diabetes Experts at ADA Meeting
Researchers told they could no longer attend the annual scientific sessions
medpagetoday.com
Rumor that the @amdiabetesassn.bsky.social is standing with …..the administration and denouncing their 5 colleagues (including the EiC of Diabetes Care) for violating ‘code of conduct’ Maybe the attendees should walk out. This is disgraceful from the ADA if true #ADA2026
Swapnil Hiremath 🍁🇨🇦@hswapnil.medsky.social · 2mo agoCrazy happenings at the #ADA26 Cops show up, snatch papers and shove scientists out www.medpagetoday.com/special-repo...
And FIND CKD is live already on NEJM www.nejm.org/doi/full/10.... #ERA26
Finerenone in Persons with Chronic Kidney Disease without Diabetes | NEJM
In randomized trials, finerenone, a nonsteroidal mineralocorticoid receptor antagonist, improved kidney and cardiovascular outcomes in patients with type 2 diabetes and chronic kidney disease (CKD)...
nejm.org
Final GFR results from Atrasentan (ALIGN) in the Lancet Underwhelming to me - the Flozin + Atrasentan looks pretty good OTOH www.thelancet.com/journals/lan... Simulpubs from #ERA26
Atrasentan in patients with IgA nephropathy (ALIGN): final 2·5-year results from a randomised, double-blind, placebo-controlled, phase 3 trial
Atrasentan reduced proteinuria and preserved kidney function after 2·5 years. This effect was present with or without concomitant SGLT2 inhibitor use. Atrasentan was well tolerated.
thelancet.com
Short-term discontinuation due to adverse events was lowest for #ARB monotherapy and ARB plus calcium channel blocker regimens, compared with placebo. Combination therapies generally showed greater tolerability than monotherapies. ja.ma/436Phd6
✨Exciting news #NephtSky The new #NephJC editorial interns are here! 📢Give them a follow and make them feel at home 👉 @drbarbateba.bsky.social @ancast13.bsky.social @kiddokidney.bsky.social @andrewdelaat.bsky.social @farahwehbe92.bsky.social 👇👇 www.nephjc.com/news/2025/6/...
NephJC Internship 2026-2027 — NephJC
Introducing NephJC’s brand new editorial internship class of 2026-2027
nephjc.com
Even with federal grants largely restored, scientists say the Trump administration is still preventing those funds from reaching them. The consequences, they say, are already becoming clear.
Researchers say the Trump administration is finding new ways to punish science
Even with federal grants largely restored, scientists say the Trump administration is still preventing those funds from reaching them. The consequences, they say, are already becoming clear.
n.pr
Somewhere in this house is a large graduation banner that 2 years ago I put away and distinctly remember saying “When I can’t remember where I put this, tell me it’s in X” but nobody remembers the X! 😩
a cartoon of tom and jerry in a living room with a table and chairs
ALT: a cartoon of tom and jerry in a living room with a table and chairs
media.tenor.com
18: Mom. [My prom dress has been in a pile on my bedroom floor for a month] Can you steam it quick before tonight? Me: Yes I can.
An interim analysis of a phase 3 trial involving patients with IgA nephropathy showed that 39 weeks of treatment with telitacicept led to a greater reduction in the 24-hour urinary protein-to-creatinine ratio than placebo. Full TELIGAN trial results: https://nej.md/4uFpMLz
73% of mothers with kids under 18 are in the workforce. More than flowers or brunch, working moms need: -Paid family leave -Equal pay -Universal childcare -Universal healthcare (But get your mom flowers, too)
Do you struggle with FSGS? Are you a sparsentan fan but asking, what's next? TRPC6 inhibitors completed a phase 2 study! Are we closing in on a common pathway of FSGS pathology? Blog by @drsaivani.bsky.social & @sayalibthakare.bsky.social #NephSky #MedSky www.nephjc.com/news/trcpc6inhibition-fsgs
Is TRPC6 inhibition for FSGS a trick or a treat? — NephJC
This week, we will discuss a phase 2 trial of the TRPC6 inhibitor BI 764198 in FSGS—an early signal for a podocyte-targeted therapy showing proteinuria reduction but set against small numbers, heterog...
nephjc.com
⏳ Deadline in a few days! Want to level up your science‑communication game? 👇👇Apply to the #NephJC Editorial Internship and help craft the conversations that move nephrology forward www.nephjc.com/news/nephjc-...
Announcing the NephJC Editorial Internship — NephJC
Are you a curious, motivated nephrology fellow or early‑career faculty member with a passion for science communication? NephJC is inviting a small group of talented individuals to join our Editorial I...
nephjc.com
Federal Policy Changes and Career Stability Among NIH K-Award Recipients Among NIH K-award recipients, 96% perceived recent federal policy changes as negatively affecting research career stability; 18% report being much less likely to continue research vs 1 year ago jamanetwork.com/journals/jam...
Federal Policy Changes and Career Stability Among NIH K-Award Recipients
This cross-sectional study uses survey data to evaluate how National Institutes of Health (NIH) K awardees perceive the effects of federal policy on research career stability and intentions to pursue ...
jamanetwork.com
